
@alexandrer81988 @opus__33 @tabler_tim @loscharlos reversinglongcovid.org for those talking about JAK inhibitors like Baricitinib: a major Phase 3 trial (REVERSE-LC) is now enrolling to study its impact on neuro-symptoms. If you have LC-triggered ME/CFS, there are 18 U.S. enrolling sites
English




